We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+26.88%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$226M
AUM Growth
–
Cap. Flow
+$205M
Cap. Flow
% of AUM
90.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
10
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
+$74M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$48.5M |
| 3 |
Pacira BioSciences
PCRX
|
+$23.8M |
| 4 |
Verastem
VSTM
|
+$17.4M |
| 5 |
KBIO
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
|
+$14.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 64.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $81M | 35.87% |
+2,880,485
| New | +$74M |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $60M | 26.55% |
+2,441,344
| New | +$48.5M |
|
|
3
Verastem
VSTM
$507M
| $24.1M | 10.67% |
+144,681
| New | +$17.4M |
|
|
4
Pacira BioSciences
PCRX
$1.01B
| $23.9M | 10.58% |
+824,255
| New | +$23.8M |
|
|
KBIO
5
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $14.9M | 6.6% |
+329,116
| New | +$14.9M |
|
6
Altimmune
ALT
$554M
| $10.1M | 4.47% |
+21,159
| New | +$10.5M |
|
|
AVEO
7
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $5.52M | 2.44% |
+220,896
| New | +$9.44M |
|
|
ZLCS
8
DELISTED
ZALICUS INC COM NEW
ZLCS
| $3.12M | 1.38% |
+927,830
| New | +$3.32M |
|
|
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
| $1.9M | 0.84% |
+1,590
| New | +$1.68M |
|
|
PETX
10
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.36M | 0.6% |
+180,505
| New | +$1.43M |
|
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM